Literature DB >> 11781695

An mtDNA mutation, 14453G-->A, in the NADH dehydrogenase subunit 6 associated with severe MELAS syndrome.

K Ravn1, F Wibrand, F J Hansen, N Horn, T Rosenberg, M Schwartz.   

Abstract

We report a novel point mutation in the gene for the mitochondrially encoded ND6 subunit of the NADH:ubiquinone oxidoreductase (complex I of the respiratory chain) in a patient with MELAS syndrome. The mutation causes a change from alanine to valine in the most conserved region of the ND6 subunit. The patient was heteroplasmic for the mutation in both muscle and blood, but the mutation was not detected in the patient's mother. A marked reduction of complex I activity was found in the patient's muscular tissue. This is the first report of a mutation in the ND6 subunit causing MELAS. Our data confirm the genetic heterogeneity in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome, and confirms that MELAS can be caused by mutation in polypeptide-coding mtDNA genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11781695     DOI: 10.1038/sj.ejhg.5200712

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  25 in total

Review 1.  Mitochondrial complex I: structure, function and pathology.

Authors:  Rolf J R J Janssen; Leo G Nijtmans; Lambert P van den Heuvel; Jan A M Smeitink
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

Review 2.  Maternally inherited mitochondrial respiratory disorders: from pathogenetic principles to therapeutic implications.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  Mol Genet Metab       Date:  2020-06-27       Impact factor: 4.797

3.  Impaired Bioenergetics in Mutant Mitochondrial DNA Determines Cell Fate During Seizure-Like Activity.

Authors:  Stjepana Kovac; Elisavet Preza; Henry Houlden; Matthew C Walker; Andrey Y Abramov
Journal:  Mol Neurobiol       Date:  2018-04-27       Impact factor: 5.590

4.  Mutation in the mitochondrial tRNA(Val) causes mitochondrial encephalopathy, lactic acidosis and stroke-like episodes.

Authors:  Catherine Glatz; Kristin D'Aco; Sabrina Smith; Neal Sondheimer
Journal:  Mitochondrion       Date:  2011-04-20       Impact factor: 4.160

Review 5.  Mitochondrial dysfunction in neurological disorders with epileptic phenotypes.

Authors:  Gábor Zsurka; Wolfram S Kunz
Journal:  J Bioenerg Biomembr       Date:  2010-12       Impact factor: 2.945

Review 6.  Non-coding RNAs and disease: the classical ncRNAs make a comeback.

Authors:  Rogerio Alves de Almeida; Marcin G Fraczek; Steven Parker; Daniela Delneri; Raymond T O'Keefe
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

7.  Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease.

Authors:  Yohei Kirino; Takehiro Yasukawa; Shigeo Ohta; Shigeo Akira; Kaisuke Ishihara; Kimitsuna Watanabe; Tsutomu Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

8.  Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS.

Authors:  Mahsa Mehrazin; Sara Shanske; Petra Kaufmann; Ying Wei; Jorida Coku; Kristin Engelstad; Ali Naini; Darryl C De Vivo; Salvatore DiMauro
Journal:  Am J Med Genet A       Date:  2009-02-15       Impact factor: 2.802

9.  The 13042G --> A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype.

Authors:  M L Valentino; P Barboni; C Rengo; A Achilli; A Torroni; R Lodi; C Tonon; B Barbiroli; F Fortuna; P Montagna; A Baruzzi; V Carelli
Journal:  J Med Genet       Date:  2006-07       Impact factor: 6.318

Review 10.  Unique features of animal mitochondrial translation systems. The non-universal genetic code, unusual features of the translational apparatus and their relevance to human mitochondrial diseases.

Authors:  Kimitsuna Watanabe
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.